The Drug Supply Chain Security Act is a law that was implemented in 2013 by the FDA. It outlines critical steps to build an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States. By 2023, the system will electronically exchange drug information at the individual package level providing end to end visibility across the supply chain.
Needless to say, this is a complex law that has brought momentous change to the way most pharmacies track and trace their products. Requirements have rolled out gradually over a 10-year time span, all leading up to full interoperability in 2023.
Our Expertise
Our expertise is focused on complex regulatory environments – tracking changes and how they impact the people, products and industries involved. Compliance and policy are integral pieces of any business strategy, and structure is a necessity for you to adapt to new needs, and that’s where we come in. The InfiniTrak team crafts creative and practical solutions that address every last detail and bring you assurance that we are thinking about both the law and technology that supports the latest regulatory requirements.
Understand the Law!
Understanding the law – From the basic requirements to the specifics of compliance, we’ve boiled it down to the basics you really need to know now!
The FDA guidance letter is a delay in enforcement with the expectation pharmacies continue to progress toward DSCSA implementation. The FDA would like all trading partners to...
DSCSA Compliance Solution for Asembia Pharmacy Members Asembia has partnered with InfiniTrak to provide a complete DSCSA Solution for pharmacies. InfiniTrak takes the burden, of...
Micro Merchant Systems Announces Partnership with InfiniTrak to Facilitate an Integrated Pharmacy DSCSA Compliance Solution. July 12, 2023 – Micro Merchant Systems has announced a...